Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
Labcorp Holdings Inc LH
$254.42
▼ -1.14%
($-2.93)
Index member:
S&P 500
Open
$255.77
Prev Close
$257.35
Day Range
$254.00 – $257.30
52W Range
$239.67 – $293.72
Market Cap
$21.10B
P/E (TTM)
22.16
Beta
0.91
Div Yield
1.13%
EPS (TTM)
$11.29
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1991-04-24 |
| Shares Out. | 82,190,000 |
| Website | labcorp.com/ ↗ |
| Phone | 13362291127 |
Labcorp Holdings Inc is a publicly traded company under the ticker symbol LH on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
29 analysts (2026-05-01)
📰 Latest News for LH
TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash
Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down
Labcorp Holdings (LH) is Positioned to Benefit from Demographic Trends
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
Labcorp Expands Collaboration With Epic; Labcorp's Full Test Menu To Be Available Through Aura, Epic's Unified Platform For Ordering And Receiving Lab Results
3 Healthcare Stocks We Steer Clear Of
LH vs. CRL: Which Stock Is the Better Value Option?